Trial signals major milestone in hunt for new TB drugs
Monday, July 23, 2012 - 19:30
in Health & Medicine
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a new study. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.